MediciNova
MNOV
33 hedge funds and large institutions have $7.04M invested in MediciNova in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 15 reducing their positions, and 7 closing their positions.
100% more call options, than puts
Call options by funds: $10K | Put options by funds: $5K
4% more capital invested
Capital invested by funds: $6.78M → $7.04M (+$264K)
0.23% more ownership
Funds ownership: 9.53% → 9.76% (+0.23%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 35 → 33 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
87% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
+$189K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$185K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$3.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$53.7K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$41.7K |
| 3 |
JP Morgan Chase
New York
|
-$39.4K |
| 4 |
Renaissance Technologies
New York
|
-$28.6K |
| 5 |
Squarepoint
New York
|
-$21.5K |
MNOV Hedge Fund Activity: Q2 2024 in Review
33 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2024, worth a combined $7.04M — up 3.9% from $6.78M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MNOV and 5 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 2 added.
The largest buyer was Charles Schwab, opening a new position worth an estimated $189K. The largest seller was Dimensional Fund Advisors, cutting an estimated $53.7K.
- 33 institutional investors held MediciNova (MNOV) as of Q2 2024, down from 35 in Q1 2024.
- Funds reported $7.04M of MediciNova stock for Q2 2024, up 3.9% quarter-over-quarter.
- 5 funds opened new MediciNova positions in Q2 2024 and 7 closed out, a net change of -2 holders.
- The largest MediciNova buyer in Q2 2024 was Charles Schwab, an estimated $189K added.
- The largest MediciNova seller in Q2 2024 was Dimensional Fund Advisors, an estimated $53.7K sold.
Based on aggregated 13F filings for Q2 2024.